Neurotech Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Neurotech Pharmaceuticals's estimated annual revenue is currently $19.1M per year.
- Neurotech Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Neurotech Pharmaceuticals has 123 Employees.
- Neurotech Pharmaceuticals grew their employee count by 31% last year.
Neurotech Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Commercial Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Communications Officer (CCO) | Reveal Email/Phone |
5 | Head Sales - U.S. | Reveal Email/Phone |
6 | Head Medical Affairs | Reveal Email/Phone |
7 | Head Commercial Finance | Reveal Email/Phone |
8 | Head Quality Control/Sr. Director Quality Control | Reveal Email/Phone |
9 | VP, Head Quality | Reveal Email/Phone |
10 | VP Manufacturing, Facilities, Warehouse and Logistics | Reveal Email/Phone |
Neurotech Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 16 | -20% | N/A | N/A |
#2 | $0.3M | 2 | -60% | N/A | N/A |
#3 | $2.8M | 68 | 48% | $59M | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $1.1M | 7 | 40% | N/A | N/A |
#6 | $1.1M | 7 | 17% | N/A | N/A |
#7 | $0.4M | 5 | -44% | N/A | N/A |
#8 | $0.3M | 2 | -71% | N/A | N/A |
#9 | $1.9M | 12 | 0% | N/A | N/A |
#10 | $19.1M | 123 | 31% | N/A | N/A |
What Is Neurotech Pharmaceuticals?
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients.Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.
keywords:N/AN/A
Total Funding
123
Number of Employees
$19.1M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $23.2M | 129 | -20% | N/A |
#2 | $39M | 140 | 1% | N/A |
#3 | $48.2M | 151 | 9% | N/A |
#4 | $53.7M | 271 | 10% | N/A |
#5 | $75M | 377 | 2% | N/A |